Publication:
Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up results

dc.contributor.authorMarcellin, Patrick
dc.contributor.authorBonino, Ferruccio
dc.contributor.authorLau, George
dc.contributor.authorFarci, Patrizia
dc.contributor.authorYurdaydin, Cihan
dc.contributor.authorPiratvisuth, Teerha
dc.contributor.authorLuo, Kangxian
dc.contributor.authorHadziyannis, Stephanos J.
dc.contributor.authorWang, Yuming
dc.contributor.authorPopescu, Matei
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.date.accessioned2022-11-01T08:02:40Z
dc.date.available2022-11-01T08:02:40Z
dc.date.issued2006-10
dc.descriptionBu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.citationMarcellin, P. vd. (2006). ''Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up resultst''. Hepatology, 44(4), Suplement 1, 550A-550A.en_US
dc.identifier.endpage550Atr_TR
dc.identifier.issn0270-9139
dc.identifier.issue4, Supplement 1en_US
dc.identifier.startpage550Atr_TR
dc.identifier.urihttp://hdl.handle.net/11452/29292
dc.identifier.volume44tr_TR
dc.identifier.wos000241362302066
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.journalHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleSuppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up resultsen_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalıtr_TR
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: